Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Disease overview

Viral
Evidence-backed information EN 5/7 applicable sections · ZH 5/7 applicable sections Updated Oct 23, 2026

Hepatitis C is a liver inflammation caused by the hepatitis C virus, capable of producing both short-term and long-term illness that may be life-threatening [1]. Globally, an estimated 47 million people live with chronic infection and about 0.9 million new infections occur each year [1]. In 2024, roughly 239,000 deaths were attributed to the disease, principally from cirrhosis and primary liver cancer [1]. No effective vaccine exists, though antiviral treatment can cure most infections [1].

Read the full clinical and epidemiological profile 6
Definition

Hepatitis C is a viral infection that affects the liver and is caused by the hepatitis C virus [1]. It can present as either acute or chronic illness and may range from mild to a serious, lifelong condition [1].

Clinical features

The infection can cause both acute and chronic hepatitis, with severity varying from a mild illness to a serious, lifelong disease including cirrhosis and cancer [1]. Reported symptoms include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, and jaundice [1].

Epidemiology

Worldwide, approximately 47 million individuals have chronic hepatitis C virus infection, with around 0.9 million new infections annually [1]. The World Health Organization estimated about 239,000 deaths in 2024, mostly due to cirrhosis and hepatocellular carcinoma [1]. Systematic review evidence indicates hepatitis C infection is associated with increased hospitalizations, longer length of stay, and higher readmissions, reflecting a substantial burden on healthcare systems [2].

Transmission

The hepatitis C virus is bloodborne and spreads through contact with infected blood [1]. Principal routes include unsafe injections and medical procedures, unscreened blood transfusions, sharing of needles and syringes among people who inject drugs, and sexual practices that result in blood exposure [1].

Prevention

No effective vaccine against hepatitis C is currently available, so prevention relies on avoiding contact with infected blood [1]. Preventive approaches focus on reducing blood exposure through safer injection and transfusion practices and infection control in health care [1].

Coding Register
ICD-10
B17.1-B18.2
ICD-11
1E50.2-1E51.1
Data coverage

Loading current data…

Country surveillance trends

Choose a country, source, and measure. Each line retains its published reporting period and definition.

Loading data…

Coverage

Reporting countries and regions

The map shows reporting coverage. Select a measure or open a shaded location to inspect its data.

Loading current data…

Surveillance pattern

Year × month seasonality by country

Review one country’s published monthly values by year. Empty cells indicate values the source did not publish.

Research Radar

Recent related research

View all research →

Showing 5 of 91 related publications.

Literature links are provided for discovery and do not alter or validate the surveillance series above.

Loading official alerts…

Downloads and methods

Choose a time range and download CSV, JSON or XLSX files.

Partitioned public data

Choose a time range and format

Download archives have their own release date and may differ from the live curves.